Keeping Drug Costs Low
Clinical Savings Guaranteed at 3:1 ROI
58% Prior Authorization Approval Rate
EmpiRx Health recently issued a press release strongly supporting the growing efforts by Congress and the Federal Trade Commission to rein in the largest PBM companies and their “anticompetitive” practices that have contributed to rising prescription drug costs. The House Committee on Oversight and Accountability held hearings earlier in July to examine how the big three PBMs have exploited their size and influence to expand their profits at the expense of patients and the organizations that sponsor pharmacy benefits plans. These hearings followed the release of the committee’s report on the practices of the biggest PBMs.
In EmpiRx Health’s press release, our CEO Danny Sanchez commented that EmpiRx Health and many others in the pharmacy care industry “wholeheartedly support the work of the Oversight Committee and the FTC in addressing the deeply flawed business practices of the big three PBMs.” You can read the full copy of our press release here.
Population Health Management Engine Identified: A 37-year-old patient was prescribed medication that was not FDA-approved for their condition. Upon careful review of the patient’s chart notes, it was identified that the patient had received treatment for seven months with her previous insurance company and had no clinical response to treatment.
Original Rx: Acthar HP gel 80U/ml @ $87,000 per dose
Our Clinical Pharmacist collaborated with the patient’s prescribing physician to discuss an alternate treatment: Rituxan, which has shown effectiveness in clinical studies. The patient’s symptoms resolved after the first infusion cycle, allowing her to resume her work and normal activities.
New Therapy: Rituxan 1g @ $10,000 per dose
$482,000 Annual Plan Savings achieved.
Featuring Christina Lilley, VP of Clinical Concierge Services
“What I love most about my job and working at EmpiRx Health would be that I’m really passionate about the opportunity to make a tangible difference in patient care through our clinically-driven approach… Working at EmpiRx Health allows me to be a part of a forward thinking team dedicated to improving healthcare outcomes and pushing the boundaries of pharmacy care.” – Christina Lilley, VP of Clinical Concierge Services at EmpiRx Health
Watch the full video here.
EmpiRx Health has been certified again as a Great Place to Work®! This certification is a testament to our unending commitment to fostering a positive, inclusive and encouraging workplace culture where every team member can thrive and do the best work of their careers. We believe that a great workplace is built on trust, respect, and empowerment. This recognition reflects the dedication of our incredible team which works hard every day to provide the highest quality pharmacy care to our clients and members.
Thank you to our employees for making EmpiRx Health a fantastic place to work and for delivering on our mission to keep patients healthy and happy while substantially lowering the costs of prescription drugs — guaranteed.
Danny Sanchez is the Chief Executive officer of EmpiRx Health, the leading clinically-driven pharmacy benefits management company. He is responsible for strengthening and expanding EmpiRx Health’s position as a driver of transformative change in the pharmacy benefits care industry. Danny leads the company’s mission to build and grow an innovative, high performance organization that puts the needs and interests of its customers first.
Danny’s career has been motivated by his belief that helping people access and adhere to the right therapies improves their health and impacts downstream costs. He brings 20+ years of healthcare technology experience to his role, along with a proven track record of developing and deploying innovative solutions that improve quality of care. He joined EmpiRx Health from Omnicell, where he held various leadership positions over his 16+ year tenure, and cultivated a focus on healthcare automation, patient adherence, and Population Health solutions. At Omnicell, he oversaw the launch of EnlivenHealth as General Manager, piloting numerous successful initiatives that harnessed technology to transform health and business outcomes.
His prior experience includes 3 years within the Medical Automation Division of McKesson Corporation. Danny holds degrees from Florida A&M University and from the H. Wayne Huizenga School of Business and Entrepreneurship at Nova Southeastern University.
Dr. Polina Kogan is the Executive Vice President and Chief Pharmacy Officer at EmpiRx Health, driving clinical strategy-through-execution at value-based PBM, with a clinically-focused and tech-enabled approach to bending the Rx cost curve. In her role, Dr. Kogan is revolutionizing PBM-based care management by directing the industry’s only pharmacy-driven population health management model, that includes AI-based risk profiling and predictive modeling, deep physician engagement, and white-glove complex case management.
Dr. Kogan has an outstanding track record of transforming clinical operations and building clinical strategies from the ground-up. Her over 25-year career spans across PBM, health plan, hospital, and retail pharmacy.
Prior to EmpiRx Health, Dr. Kogan built and led the pharmacy unit at VNSNY, a leading provider of managed care services for Medicare and Medicaid plans. Polina has held leadership roles at major New York teaching hospitals and is an active member of the Academy of Managed Care Pharmacy (AMCP) serving multiple terms on AMCP Committees within her 18-year tenure. She holds a Doctor of Pharmacy degree from the University of Florida and a Bachelor of Science degree in Pharmacy from Long Island University.
Ziad Rubaie is the Chief Growth Officer at EmpiRx Health and is responsible for all aspects of EmpiRx Health’s growth and the expansion of its national customer footprint. Ziad is a respected leader in the healthcare industry with more than 27 years of experience leveraging an impressive network of healthcare consultants to build deep strategic partnerships. He has a proven track record of driving exponential growth and comes to EmpiRx Health after 3 years as the Chief Business Development Officer at Consociate Health, a boutique TPA with a rapidly expanding national footprint.
His prior background includes a highly-successful 9-year tenure at CastiaRx, formerly known as LDI Integrated Pharmacy, where he established and delivered nationwide pharmacy solutions that exceeded industry results. Ziad also served as EVP of Sales and Marketing for Essex Dental & Vision Benefits, a subsidiary of Delta Dental of Missouri. Ziad started his healthcare career in 1995 with many roles including Assistant Vice President of Sales at Healthscope Benefits.
Ziad attended business school at the University of Michigan.
Vivek Dabke is the Executive Vice President and Chief Information Officer at EmpiRx Health, responsible for technology strategy-through-execution and digital innovation, at the industry’s only value-based PBM, with a clinically-focused and tech-enabled approach to bending the Rx cost curve.
Vivek is a senior IT leader with extensive experience in managing technology organizations and large-scale digital transformations across Fortune 500 and mid-sized organizations, while significantly improving the customer experience across external and internal stakeholders.
Vivek’s background includes senior technology leadership roles at Cigna, QualCare (a Cigna Co.), and Pfizer. Vivek has also successfully built and led a boutique IT consulting firm specializing in Big Data analytics, technology delivery, digital transformation, and cloud migrations, that provided solutions and services across a broad spectrum of industries. He has a Bachelor of Science degree in Electrical engineering.
Greg Mueller is Executive Vice President of Client Management and Operations for EmpiRx Health, the leading clinically-driven, customer-first pharmacy benefits management company. Greg is responsible for driving client and member satisfaction by providing best-in-class implementation and service experiences.
Greg is an experienced business leader with a relentless focus on customer success. By combining strategic thinking with a hands-on approach to process improvement and technology integration, he has consistently delivered results that not only meet but exceed customer expectations. Throughout his career, Greg has consistently put the customer experience center stage, driving results that positively impact the bottom line.
Prior to joining EmpiRx Health, Greg led Customer Enablement for EnlivenHealth®, the retail pharmacy technology division of Omnicell (Nasdaq: OMCL), the global healthcare technology company. Greg was responsible for the entire customer journey, from sale to implementation, customer support, and success.
Earlier in his career, Greg held various management and consulting roles with the AI and analytics leader SAS Institute, where he worked closely with C-level executives across multiple industries to solve complex business challenges. Greg has a Bachelor of Science in Business Administration from the University of Central Florida.
Laura Alemzadeh is the Chief Legal and Human Resources Officer at EmpiRx Health, responsible for overseeing all matters related to legal, compliance, and human resources for the company. A seasoned attorney with over two decades of legal experience, Laura has served as General Counsel for several companies across diverse industries and has extensive experience in human resources matters. Laura plays a key role on EmpiRx Health’s Senior Leadership Team, which guides the company’s continued growth as the leading clinically-driven, customer-first pharmacy benefits management company.
In her wide-ranging experience as a General Counsel, Laura has established herself as a trusted advisor and legal strategist for companies and their boards of directors. She has successfully navigated the intricate legal and regulatory landscapes of numerous industries, including healthcare, technology, and manufacturing. Laura's leadership has been instrumental in shaping corporate policies, ensuring regulatory compliance, and mitigating risks, contributing significantly to the growth and success of the companies with which she has worked.
An active participant in and contributor to the legal community, Laura frequently shares her insights at industry conferences. She is the immediate past Chair of ACC New York City’s CLO group, and past board member of ACC New York City. Laura obtained her Bachelor of Arts from University of Central Florida and her J.D. from York University’s Osgoode Hall in Toronto, Canada.
John Ridyard is Executive Vice President of Strategy, Product and Marketing for EmpiRx Health, a leading pharmacy benefits management company that is dedicated to putting its clients first through unmatched clinical care solutions, guaranteed cost savings, and highly personalized service. John is responsible for building the strategies and products that help clients, partners, and members to thrive, while strengthening and expanding EmpiRx Health’s brand and market leadership.
John is an experienced business leader with a proven track record of driving innovative strategies that enable organizations to grow profitably, both organically and through partnerships and acquisitions. During his career, John has been motivated by a desire to deeply understand the unmet needs of his customers, assess his organization’s internal and external capabilities to meet those needs, and work cross-functionally to deliver on them.
Prior to joining EmpiRx Health, John led the Growth and Business Operations for EnlivenHealth®, the retail pharmacy technology division of Omnicell (Nasdaq: OMCL), the global healthcare technology company. John also led the product and marketing functions for Omnicell’s Global Automation and Medication Adherence businesses.
Earlier in his career, John was a consultant with Health Advances LLC, a strategy and management consultancy. He has a Bachelor of Arts degree in Molecular Biology and Economics from Connecticut College.
Rand Greenblatt is Chief Financial Officer of EmpiRx Health, the leading clinically-driven pharmacy benefits management company that always puts customers and members first. As CFO, Rand leads EmpiRx Health’s financial strategy and operations, leveraging his deep financial expertise and business transformation skills to help foster a strong culture of fiscal stewardship, people development and client dedication. In addition to his extensive experience in the PBM and healthcare sectors, Rand has held senior financial and operational roles in insurance, investments, and business services.
Prior to joining EmpiRx Health, Rand served as Chief Financial Officer and Chief Administrative Officer of Elixir, a leading pharmacy care solutions provider. He led a turnaround at Elixir, which was sold to MedImpact Healthcare Systems in early 2024. Previously, Rand was Divisional CFO for the Technology Division of the global insurance company Chubb. His efforts in integrating global internal controls and enhancing balance sheet analytics helped to set new standards for financial management and strategic decision-making at Chubb.
Earlier in his career, Rand served in senior financial, business development and audit positions for major organizations, including Independence Blue Cross (IBX), Cigna Healthcare and Deloitte.
A Certified Public Accountant, Rand earned his BS in Accounting from the Alfred Lerner College of Business & Economics at the University of Delaware. From 2013 to 2017, he was a member of the Regional Board of Directors of the American Cancer Society. In addition, Rand has served as an Advisory Board Member for the Philadelphia Chapter of the CFO Leadership Council.
